menu

Medical Industry Feature: Neoadjuvant Chemotherapy: Downstaging to Breast-Conserving Surgery in Patients

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
Merck Oncology

Neoadjuvant Chemotherapy: Downstaging to Breast-Conserving Surgery in Patients

Program Information
Recommended
Neoadjuvant Chemotherapy: Downstaging to Breast-Conserving Surgery in Patients
RestartResume
Even though neoadjuvant systemic therapy may come with many benefits for the appropriate breast cancer patient, it can be underutilized.
  • Sponsored by

  • Overview

    To help address the underutilization of neoadjuvant systemic therapy, Dr. Monica Morrow a surgical oncologist who specializes in treating breast cancer, defines the benefits of this therapy in addition to addressing the importance of involving a multidisciplinary team in neoadjuvant treatment decisions.

    ONCO-1241030-0011 10/18

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/19/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.